Mutation of the SNF2 family member Chd2 affects mouse development and survival

The chromodomain helicase DNA‐binding domain (Chd) proteins belong to the SNF2‐like family of ATPases that function in chromatin remodeling and assembly. These proteins are characterized by the presence of tandem chromodomains and are further subdivided based on the presence or absence of additional structural motifs. The Chd1–Chd2 subfamily is distinguished by the presence of a DNA‐binding domain that recognizes AT‐rich sequence. Currently, there are no reports addressing the function of the Chd2 family member. Embryonic stem cells containing a retroviral gene‐trap inserted at the Chd2 locus were utilized to generate mice expressing a Chd2 protein lacking the DNA‐binding domain. This mutation in Chd2 resulted in a general growth delay in homozygous mutants late in embryogenesis and in perinatal lethality. Animals heterozygous for the mutation showed decreased neonatal viability and increased susceptibility to non‐neoplastic lesions affecting most primary organs. In particular, approximately 85% of the heterozygotes showed gross kidney abnormalities. Our results demonstrate that mutation of Chd2 dramatically affects mammalian development and long‐term survival. J. Cell. Physiol. 209: 162–171, 2006. © 2006 Wiley‐Liss, Inc.

[1]  J. Min,et al.  Structural basis for specific binding of Polycomb chromodomain to histone H3 methylated at Lys 27. , 2003, Genes & development.

[2]  I. Targoff,et al.  Two forms of the major antigenic protein of the dermatomyositis-specific Mi-2 autoantigen. , 1996, Arthritis and rheumatism.

[3]  E. Koonin,et al.  The chromo superfamily: new members, duplication of the chromo domain and possible role in delivering transcription regulators to chromatin. , 1995, Nucleic acids research.

[4]  D. Nilasena,et al.  Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen. , 1995, The Journal of clinical investigation.

[5]  G. Cagney,et al.  Methylation of Histone H3 by Set2 in Saccharomyces cerevisiae Is Linked to Transcriptional Elongation by RNA Polymerase II , 2003, Molecular and Cellular Biology.

[6]  S. Khorasanizadeh,et al.  Double chromodomains cooperate to recognize the methylated histone H3 tail , 2005, Nature.

[7]  V. Iyer,et al.  The chromo domain protein Chd1p from budding yeast is an ATP‐dependent chromatin‐modifying factor , 2000, The EMBO journal.

[8]  J. T. Kadonaga,et al.  Distinct activities of CHD1 and ACF in ATP-dependent chromatin assembly , 2005, Nature Structural &Molecular Biology.

[9]  M. Kok,et al.  CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system , 2003, Oncogene.

[10]  M. Renz,et al.  The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase involved in transcriptional activation. , 1995, Arthritis and rheumatism.

[11]  S. Sif.  ATP‐dependent nucleosome remodeling complexes: Enzymes tailored to deal with chromatin , 2004, Journal of cellular biochemistry.

[12]  John R. Yates,et al.  Chd1 chromodomain links histone H3 methylation with SAGA- and SLIK-dependent acetylation , 2005, Nature.

[13]  Yasuyuki Ohkawa,et al.  Chromatin remodelling in mammalian differentiation: lessons from ATP-dependent remodellers , 2006, Nature Reviews Genetics.

[14]  Han G Brunner,et al.  Mutations in a new member of the chromodomain gene family cause CHARGE syndrome , 2004, Nature Genetics.

[15]  J. Connor,et al.  Confirmation of CHD7 as a cause of CHARGE association identified by mapping a balanced chromosome translocation in affected monozygotic twins , 2005, Journal of Medical Genetics.

[16]  J. Belmont,et al.  SNP genotyping to screen for a common deletion in CHARGE Syndrome , 2005, BMC Medical Genetics.

[17]  F. Collins,et al.  Characterization of the CHD family of proteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Palmer,et al.  Characterization of the imitation switch subfamily of ATP-dependent chromatin-remodeling factors in Saccharomyces cerevisiae. , 1999, Genes & development.

[19]  B. Feuerstein,et al.  Molecular cytogenetic analysis of chromosomes 1 and 19 in glioma cell lines. , 2005, Cancer genetics and cytogenetics.

[20]  Conrad C. Huang,et al.  BayGenomics: a resource of insertional mutations in mouse embryonic stem cells , 2003, Nucleic Acids Res..

[21]  Q. Feng,et al.  The NuRD complex: linking histone modification to nucleosome remodeling. , 2003, Current topics in microbiology and immunology.

[22]  Hien G. Tran,et al.  Chromatin remodeling protein Chd1 interacts with transcription elongation factors and localizes to transcribed genes , 2003, The EMBO journal.

[23]  K. Robinson,et al.  Replication-Independent Assembly of Nucleosome Arrays in a Novel Yeast Chromatin Reconstitution System Involves Antisilencing Factor Asf1p and Chromodomain Protein Chd1p , 2003, Molecular and Cellular Biology.

[24]  R. Perry,et al.  DNA-binding and chromatin localization properties of CHD1 , 1995, Molecular and cellular biology.

[25]  W. Skarnes.  Two ways to trap a gene in mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Weissenbach,et al.  Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 truncating mutations correlates with expression during human development , 2005, Journal of Medical Genetics.

[27]  S. Gregory,et al.  Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma , 2005, Oncogene.

[28]  T. Tsukiyama.  The in vivo functions of ATP-dependent chromatin-remodelling factors , 2002, Nature Reviews Molecular Cell Biology.

[29]  R. Perry,et al.  CHD1 interacts with SSRP1 and depends on both its chromodomain and its ATPase/helicase-like domain for proper association with chromatin , 1999, Chromosoma.

[30]  R. Perry,et al.  A mammalian DNA-binding protein that contains a chromodomain and an SNF2/SWI2-like helicase domain. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Bba,et al.  CHARGE syndrome: the phenotypic spectrum of mutations in the CHD7 gene , 2005, Journal of Medical Genetics.

[32]  J. Mattick,et al.  Edinburgh Research Explorer Identification and analysis of chromodomain-containing proteins encoded in the mouse transcriptome , 2022 .

[33]  G. Cagney,et al.  RNA Polymerase II Elongation Factors of Saccharomyces cerevisiae: a Targeted Proteomics Approach , 2002, Molecular and Cellular Biology.

[34]  A. Sands,et al.  Disruption of Ini1 Leads to Peri-Implantation Lethality and Tumorigenesis in Mice , 2001, Molecular and Cellular Biology.

[35]  J. C. Eissenberg.  Molecular biology of the chromo domain: an ancient chromatin module comes of age. , 2001, Gene.

[36]  Prim B. Singh,et al.  Mammalian chromodomain proteins: their role in genome organisation and expression. , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[37]  D. Reinberg,et al.  Facts about FACT and transcript elongation through chromatin. , 2004, Current opinion in genetics & development.

[38]  J. Tamkun,et al.  The Drosophila trithorax group protein Kismet facilitates an early step in transcriptional elongation by RNA Polymerase II , 2005, Development.

[39]  E. Schuster,et al.  CHD5 defines a new subfamily of chromodomain-SWI2/SNF2-like helicases , 2002, Mammalian Genome.

[40]  Youngchang Kim,et al.  Molecular basis for the discrimination of repressive methyl-lysine marks in histone H3 by Polycomb and HP1 chromodomains. , 2003, Genes & development.

[41]  R. Kingston,et al.  Mammalian SWI-SNF Complexes Contribute to Activation of the hsp70 Gene , 2000, Molecular and Cellular Biology.

[42]  D. Bentley,et al.  Altered nucleosome occupancy and histone H3K4 methylation in response to ‘transcriptional stress’ , 2005, The EMBO journal.

[43]  D. Zink,et al.  Chromodomains are protein–RNA interaction modules , 2000, Nature.

[44]  Danny Reinberg,et al.  Human but Not Yeast CHD1 Binds Directly and Selectively to Histone H3 Methylated at Lysine 4 via Its Tandem Chromodomains* , 2005, Journal of Biological Chemistry.

[45]  M. Williams.  Speculations on the pathogenesis of CHARGE syndrome , 2005, American journal of medical genetics. Part A.

[46]  Leif E. Peterson,et al.  Spectrum of CHD7 mutations in 110 individuals with CHARGE syndrome and genotype-phenotype correlation. , 2006, American journal of human genetics.

[47]  M. Bottomley.  Structures of protein domains that create or recognize histone modifications , 2004, EMBO reports.

[48]  G. Längst,et al.  The dMi‐2 chromodomains are DNA binding modules important for ATP‐dependent nucleosome mobilization , 2002, The EMBO journal.

[49]  Naoyuki Fujita,et al.  Mi-2/NuRD: multiple complexes for many purposes. , 2004, Biochimica et biophysica acta.

[50]  Rein Aasland,et al.  The many colours of chromodomains. , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.

[51]  X. de la Cruz,et al.  Do protein motifs read the histone code? , 2005, BioEssays : news and reviews in molecular, cellular and developmental biology.

[52]  R. Perry,et al.  CHD1 is concentrated in interbands and puffed regions of Drosophila polytene chromosomes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.